Dr. Lu Xianping, Founder, Chairman and President of Chipscreen Biosciences, Mr. Li Pui Leung, Chairman and Executive Director of TK Group named Chinese mainland winner and Hong Kong/Macau winner for the EY Entrepreneur Of The Year™ 2025 awards

Today, EY Greater China is pleased to announce that Dr. Lu Xianping, Founder, Chairman and President of Shenzhen Chipscreen Biosciences Co., Ltd, has been named the Chinese mainland winner, and Mr. Li Pui Leung, Chairman and Executive Director of TK Group (Holdings) Limited, the Hong Kong/Macau winner for the EY Entrepreneur Of The Year^TM 2025 awards, in recognition of their outstanding contributions to advancing new quality productive forces and driving industrial innovation. Themed “Two decades of unwavering strength, forging ahead in the new era,” this year’s program honors entrepreneurs who shoulder new-era responsibilities, make significant contributions to national prosperity and social progress, and inject strong momentum into Chinese-style modernization.

Jack Chan, EY China Chairman and Greater China Regional Managing Partner, says: “Over more than 40 years of reform and opening-up, China’s private sector has grown from nothing to a position of strength. Behind these achievements are generations of entrepreneurs who ‘dare to be the first.’ Their courage, wisdom and perseverance have been critical drivers of China’s technological progress and high-quality economic development. The awarded entrepreneurs have maintained strategic focus amid uncertainty, led innovation during industrial transformation and shouldered new-era responsibilities. Here, on behalf of EY, I would like to convey my sincere admiration and respect to the winners and I look forward to their success in the EY World Entrepreneur Of The Year^TM next year, where they will show the world the innovative vitality and appeal of Chinese enterprises in the development of new quality productivity.”

EY Entrepreneur Of the Year™ 2025 – Chinese mainland winner:
Dr. Lu Xianping
Shenzhen Chipscreen Biosciences Co., Ltd Founder, Chairman and President

Dr. Lu Xianping stands as a distinguished scientist and entrepreneur in China's innovative pharmaceutical sector. He earned a PhD in Molecular Biology from Peking Union Medical College, pursued postdoctoral research in the US, and successfully founded two biopharmaceutical companies. Driven by the mission to “develop affordable innovative drugs for ordinary people,” he chose to return to China and established Chipscreen Biosciences in 2001.

Against the backdrop of China's historical focus on generic drugs, Dr. Lu dedicated himself to researching first-in-class drugs with entirely novel mechanisms of action. By building a new drug discovery and evaluation platform based on chemical genomics and AI-assisted design, he significantly improved R&D success rates and shortened development cycles. Under his leadership, Chidamide became China's first original small-molecule anti-tumor innovative drug and the country's first pharmaceutical product to be globally licensed out. It filled a critical gap in treating peripheral T-cell lymphoma in China and extended new hope to patients with breast cancer, adult T-cell leukemia, diffuse large B-cell lymphoma and other malignancies. Chiglitazar Sodium, developed over 19 years for Type 2 diabetes, marked a historic breakthrough as the world's first PPAR-pan agonist. Both drugs have been included in China's National Reimbursement Drug List (NRDL), substantially reducing patients' financial burdens. In the current pipeline, multiple drug candidates with significant first-in-class potential are expected to deliver novel therapeutic options for chronic diseases such as Alzheimer's disease.

Dr. Lu has actively promoted improvements of China's pharmaceutical ecosystem, including the evolution of innovative drug review pathways, NRDL inclusion mechanisms and capital market reforms. Under his guidance, Chipscreen has donated over RMB700 million worth of medicines, helping more than 10,000 patients alleviate treatment costs. Dedicated to developing first-in-class therapies with novel targets, structures and mechanisms, he has been hailed by international media as “China's pioneer of original innovative drugs.”

EY Entrepreneur Of the Year™ 2025 – Hong Kong/Macau winner:
Mr. Li Pui Leung
TK Group (Holdings) Limited Chairman and Executive Director

Mr. Li Pui Leung is an entrepreneur who brings philosophical thinking into business operation. TK Group, founded in 1983 as a small mold manufacturer in Hong Kong, has grown over four decades into a global leader in one-stop precision injection molding solutions partner and has become China's largest exporter of injection molds. The Group was listed on the Hong Kong Stock Exchange in 2013 (stock code: 2283).

Mr. Li believes that “profit is a by-product of robust business operations.” In 1979, he moved to Hong Kong and began as an apprentice mold maker. In 1983, he co-founded TK Group with a starting capital of HK$100,000. Through outstanding craftsmanship, he secured his first major orders for plastic computer enclosures, earning his “first pot of gold”.

In 1984, the company narrowly avoided bankruptcy due to a failed investment. Mr. Li built trust among clients through a commitment to integrity and established the business philosophy of prioritizing risk management and professional accountability. In 2015, he pioneered the introduction of Industry 4.0 smart production lines to promote the application of AI and big data technologies.

While the company was growing and flourishing, he initiated transformation, engaging an international consulting team to assist with strategic upgrading and smooth leadership transitions. He introduced a virtual equity incentive system and a three-tier management structure and fostered a culture of shared development, aiming to build TK Group into a hub for professional talent in the industry.

Mr. Li has long served as a member of the Shenzhen Municipal Committee of the Chinese People's Political Consultative Conference and played an active role in enhancing the collaboration between Guangdong and Hong Kong. He established the “TK Care Foundation” to support employees and received the Hong Kong Special Administrative Region Honorary Award in 2025. Under his leadership, TK Group is forging ahead toward high-quality development driven by technological innovation and a strong sense of social responsibility.

-Ends-

Notes to Editors

About EY Entrepreneur Of The Year™

EY Entrepreneur Of The Year™ is the world’s most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential, and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, EY Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in 94 countries and regions. Visit us at www.ey.com/eoy for more information.

EY | Building a better working world

EY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets.

Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow.

EY teams work across a full spectrum of services in assurance, consulting, tax, strategy and transactions. Fueled by sector insights, a globally connected, multi-disciplinary network and diverse ecosystem partners, EY teams can provide services in more than 150 countries and territories.

All in to shape the future with confidence.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients, nor does it own or control any member firm or act as the headquarters of any member firm. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com.